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1144-128 Calmodulin Kinase Activity Links Green Fluorescent 
Protein Overexpression to a Cardiomyopathic 
Phenotype
Michelle S. Khoo, Rong Zhang, Chad E. Grueter, Gemin Ni, Martha A. Bass, Corrie 
Painter, Mesut Eren, Jinying Yang, Ernest C. Madu, Lisa A. Mendes, Douglas E. 
Vaughan, Roger J. Colbran, Mark E. Anderson, Vanderbilt University Medical Center, 
Nashville, TN
Background: Transgenic (TG) expression of green fluorescent protein (GFP) causes
dilated cardiomyopathy in mice by unknown mechanisms. Calmodulin kinase (CaMK)
activity and expression are increased in cardiomyopathy.
Methods: We developed TG mice with cardiac expression of GFP fused to a CaMK-spe-
cific inhibitory peptide (IP) or a scrambled inactive control peptide (CP) to test if CaMK
activity determined cardiomyopathic responses to GFP.
Results: Cardiac dysfunction followed increased GFP expression and CaMK activity in
the GFP-CP TG mice (Table; *P < 0.05). In contrast, GFP-IP TG mice with significantly
higher GFP expression were protected from developing severe cardiomyopathy com-
pared to GFP-CP TG mice. CaMK inhibition in GFP-IP TG mice disrupted the relation-
ship between GFP expression and cardiac dysfunction seen in GFP-CP TG mice. Atrial
natriuretic peptide (ANP) expression is a marker of cardiac dysfunction. ANP increased
with GFP expression in GFP-CP TG mice, suggesting that GFP over-expression acti-
vated a CaMK signaling pathway linked to cardiomyopathy. GFP IP mice had lower ANP
message levels than GFP-CP TG mice, showing that reduced CaMK activity translated
into reduced activity of this CaMK-dependent cardiomyopathic signaling pathway.
Conclusion: These findings implicate CaMK as a specific signal activated in GFP TG
cardiomyopathy and suggest the hypothesis that other types of cardiomyopathy with
abnormal protein expression may also be linked to increased CaMK activity.
1144-129 Optimal Preload Adjustment of Right Ventricular Power 
Allows for Single Beat Estimation of Contractility
Soren Schenk, Zoran B. Popovic, Patrick M. McCarthy, Yoshie Ochiai, Randall C. 
Starling, Jose L. Navia, Yoshio Ootaki, Keiji Kamohara, James D. Thomas, Kiyotaka 
Fukamachi, Cleveland Clinic Foundation, Cleveland, OH
Background Right ventricular (RV) maximal power (PWRmax) is closely related to RV
stroke work, and is a sensitive, yet, preload dependent parameter of contractility.We
hypothesized that the relationship of PWR vs end–diastolic volume (EDV), analogous to
RV stroke work vs EDV relationship (PRSW), may be linearly modeled with x-axis inter-
cept (V0PWR) corresponding to PRSW intercept (V0PRSW).
Methods Nine dogs were instrumented with pulmonary flow probe, RV micromanometer,
and conductance catheter. RV volume signals were calibrated by flow probe and
echocardiography. Data were obtained during bicaval occlusions (n=78) under various
hemodynamic conditions (baseline, atrial pacing at 90, 120, and 150 bpm, and dob-
utamine infusion) and fitted to the equation PWR = a·(EDV- V0PWR)b.
Results The PWR vs EDV relationship did not deviate from linearity (b=1.1 ± 0.6, p = NS
vs 1.0), and V0PWR correlated closely with V0PRSW (r = 0.93, p<0.0001). V0PRSW was
related to steady state EDV by equation V0PRSW =0.63·EDV-6.5 (r=0.833, p<0.0001),
allowing for single beat estimation of V0PWR (V0EST) and for preload adjustment of PWR-
max. Dividing PWRmax by the difference of EDV and V0PWR (PAMPV0-PWR) eliminated
preload dependency (± 3.0%) down to 50% of baseline EDV. Preload independency of
PAMPV0-PWR was confirmed by numerical modeling of actual data testing various
V0PWR, EDV, PRSW, and PWR. Similarly, PWRmax adjustment using V0EST (PAMPV0-
EST) showed preload independency down to 75% of baseline EDV. Enhancing contractil-
ity by dobutamine increased PAMPV0-PWR and PAMPV0-ES from 173 ± 87 to 417 ± 225
W/ml·104 and 178 ± 48 to 464 ± 284 W/ml·104, respectively (both p=0.01), accompanied
by increase of PRSW from 13.6 ± 4.3 to 30.1 ± 17.4 mm Hg (p<0.05). Both PAMPV0-PWR
and PAMPV0-EST correlated closely with PRSW (r=0.86, p<0.001; r=0.93, p<0.001).
Conclusion Optimal preload adjustment of RV PWRmax can be achieved by considering
linear PWR vs EDV relationship and V0PWR presence. Adjusting PWRmax by steady
state EDV and V0EST (PAMPV0-EST) may be a useful, preload independent estimate of
RV contractility that can potentially be determined non–invasively without the need for
bicaval occlusion.
1144-130 Calpain Activation and Inhibition in Acute Right Heart 
Failure
Hasan A. Ahmad, Li Lu, Ya Xu, Jennifer Fox, Gregory G. Schwartz, Clifford R. Greyson, 
Veterans Affairs Medical Center, Denver, CO, University of Colorado Health Sciences 
Center, Denver, CO
Right ventricular (RV) failure from acute pressure overload (RVPO) is an important cause
of morbidity and mortality in patients. We previously showed that RV contractile dysfunc-
tion develops during experimental RVPO in pigs in the absence of RV ischemia, and per-
sists after normal loading conditions are restored. We hypothesized that RV dysfunction
from RVPO is due in part to activation of the calcium sensitive protease calpain, and that
calpain inhibition would attenuate RV dysfunction during RVPO.
Methods: Anesthetized open chest pigs were randomized to treatment with a calpain
inhibitor (MDL-28170, INH) or inactive vehicle (VEH) infused into the right coronary
artery, then subjected to RVPO by a constant degree of pulmonary artery constriction for
4 hrs. Contractile function was assessed by RV stroke work. In a second series of exper-
iments, calpain activation after RVPO was assessed by Western blotting of spectrin
breakdown products.
Results: At the beginning of RVPO, RV systolic pressure was 60±5 mmHg in both
groups. Compared with VEH pigs, INH pigs maintained significantly higher RV stroke
work during 4 hrs RVPO (Figure Left). RV myocardium from INH pigs showed less
calpain activation after RVPO than VEH pigs (Figure Right). Four VEH pigs, but no INH
pigs, failed to complete the protocol due to RV failure and hypotension and were not
included in this analysis.Conclusions: RV dysfunction during RVPO is attenuated by
calpain inhibition, offering a potential new therapeutic strategy in this condition. 
1144-131 AKT Signaling in Pacing-Induced Heart Failure
Radha Ananthakrishna, Michael J. Goldenthal, Gordon W. Moe, Jose Marin-Garcia, The 
Molecular Cardiology and Neuromuscular Institute, Highland Park, NJ
Background: Marked changes in energy substrate utilization occur during the progres-
sion of congestive heart failure (CHF) where free fatty acid utilization, as the primary
souce of cardiac energy is severely diminished, oxidative phosphorylation is down-regu-
lated and glucose uptake and utilization increase. While the molecular basis for the shift
in substrate utilization has not yet been elucidated, we sought to examine in the canine
model of paced-induced heart failure the potential role of the AKT pathway (previously
implicated in the events of cardiac hypertrophy) in signaling the metabolic transition of
CHF.
Methods: Left ventricular samples from early (1-2 weeks) and late (3-4 weeks) stages of
pacing-induced CHF animals (n=6 and 6 respectively) were evaluated for the levels of
both phosphorylated and non-phosphorylated AKT, as well as for AKT kinase activity and
were compared to control unpaced animals (n=6). In addition, markers of cardiac hyper-
trophy(e.g. actin, ANP, BNP, beta-MHC and SERCA 2) were assessed by immunoblot
analysis as were myocardial levels of free fatty acids and glucose.
Results: Significant increases in the phosphorylated AKT form (1.7 fold) and in AKT
kinase activity (3 fold) were found in early paced animals; these levels declined in the late
stages of pacing. Significant increases were also found in the myocardial free fatty acid
content (mean 1.0 +/- 0.27 vs. controls 0.41+/- 0.13) and only a mild decrease in glucose
level (10%) in late but not in early pacing. Markers of cardiac hypertrophy showed no dif-
ferences in the paced animals compared to control.
Conclusion: Our data demonstrate that AKT signaling pathway is a contributory element
in the early signaling events leading to the progression of pacing-induced heart failure,
accompanying the shift in substrate utilization and, contrary to the transgenic mice
model, is independent of cardiac hypertrophy. The decline in AKT phoshorylation and
kinase activation in the later stages of the pacing-induced events is also consistent with
the observed onset of myocardial apoptosis previously described in the pacing model, a
process known to be reversed by AKT pathway activation.
TORSION DYNAMICS
_max (degrees) 3.9±3.3 5.9±2.0* 0.5±1.0† 2.1±0.8*
Recoil (_5%) (degrees) -1.6±1.6 -2.0±1.6 -0.4±1.5 -1.1±1.0
Recoil Rate (d_5%/dt) 
(degrees/ms)
0.03±0.03 0.05±0.04* -0.001±0.02† 0.03±0.02*
* p < 0.05, preDobutamine vs. Dobutamine, 2-way RM ANOVA with SNK post-test.
† p < 0.05, preTIC vs. TIC, 2-way RM ANOVA with SNK post-test.
Data expressed as Mean±1SD.
TG (Line) [GFP] ng/µl CaMK Activity 
(nmol/mg/min)
Left Ventricular Fractional 
Shortening (%)
IP (L1) 
(n = 10)
89.6 ± 4.8 2.4 ± 0.2 58.9 ± 1.9
IP (L2) 
(n = 9)
125.7 ± 13.7* 3.2 ± 0.2* 46.2 ± 5.7*
CP (L1) 
(n = 10)
85.1 ± 5.9 4.3 ± 0.3* 27.7 ± 2.9*
CP (L2) 
(n = 10)
52.9 ± 1.6* 3.4 ± 0.3 54.7 ± 1.7
